<!DOCTYPE html>
<html>
<head>
<title>Cluster3-15 Analysis</title>

    <style>
            body {{
                font-family: Arial, sans-serif;
                background-color: #f5f5f5;
                color: #333333;
                margin: 0;
                padding: 0;
            }}

            h1 {{
                font-size: 2em;
                margin: 0 0 0.5em;
            }}

            ul {{
                list-style-type: none;
                margin: 0;
                padding: 0;
            }}

            li {{
                font-size: 1.2em;
                margin: 0;
            }}

            .container {{
                max-width: 800px;
                margin: 0 auto;
                padding: 2em;
                background-color: #ffffff;
            }}
        </style> 
        
</head>
<body>
<h1>Cluster3-15 System Summary</h1>
<h2>Proteins</h2>
<p>SNW1, PPIG, CHTOP, SF3B2, PNN, UNK, SETD2, BCLAF1, RSRC2, ZC3H18, SART1, SF3B4, ZC3H14, BMP2K, SRSF11, SRRM2, LUC7L3, GPATCH8, SRSF4, PRPF40A, SRSF6, WTAP, CDK11A, SFSWAP, SNRPA, CDK11B, BRD2, IK, RBM25, THRAP3, FNBP4, SF3B1, RBM17, PRPF4B, SON, BCAS2, CCDC12, CWC25, CWF19L2, PLRG1, PPIE, PRPF19, SNRPA1, SNRPB2, SYF2</p>
<h2>GPT 4 Analysis</h2><h3>Human Spliceosome-Associated Protein System</h3><h4>Summary</h4><div><summary><br>The human protein system analyzed here is primarily involved in mRNA splicing and spliceosome assembly, with a majority of the proteins localized in the nucleus and nucleoplasm. This system is composed of proteins that are known to interact with each other and are involved in various cellular processes, including mRNA processing, transcription, and cell cycle regulation. The proposed name for this system is the "Human Spliceosome-Associated Protein System" to reflect its function and location.<br></summary></div><h4>Reference</h4><div><references><br>1. Will, C. L., &amp; Lührmann, R. (2011). Spliceosome structure and function. Cold Spring Harbor Perspectives in Biology, 3(7), a003707. https://doi.org/10.1101/cshperspect.a003707<br><br>2. Matera, A. G., &amp; Wang, Z. (2014). A day in the life of the spliceosome. Nature Reviews Molecular Cell Biology, 15(2), 108-121. https://doi.org/10.1038/nrm3742<br><br>3. Papasaikas, P., &amp; Valcárcel, J. (2016). The Spliceosome: The Ultimate RNA Chaperone and Sculptor. Trends in Biochemical Sciences, 41(1), 33-45. https://doi.org/10.1016/j.tibs.2015.11.003<br><br>4. Bertram, K., Agafonov, D. E., Dybkov, O., Haselbach, D., Leelaram, M. N., Will, C. L., ... &amp; Stark, H. (2017). Cryo-EM structure of a pre-catalytic human spliceosome primed for activation. Cell, 170(4), 701-713.e11. https://doi.org/10.1016/j.cell.2017.07.011<br><br>5. Shi, Y. (2017). Mechanistic insights into precursor messenger RNA splicing by the spliceosome. Nature Reviews Molecular Cell Biology, 18(11), 655-670. https://doi.org/10.1038/nrm.2017.86<br></references></div>
<h2>Gene Feature Summary</h2>
<table>
<thead>
<tr>
<th>Feature</th><th>Number of Genes</th><th>Genes</th></tr>
</thead>
<tbody>
<tr>
<td>protein binding</td><td>42</td><td>SNW1, PPIG, CHTOP, SF3B2, PNN, SETD2, BCLAF1, RSRC2, ZC3H18, SART1, SF3B4, ZC3H14, SRSF11, SRRM2, LUC7L3, GPATCH8, SRSF4, PRPF40A, SRSF6, WTAP, SFSWAP, SNRPA, CDK11B, BRD2, IK, RBM25, THRAP3, FNBP4, SF3B1, RBM17, PRPF4B, SON, BCAS2, CCDC12, CWC25, CWF19L2, PLRG1, PPIE, PRPF19, SNRPA1, SNRPB2, SYF2</td></tr>
<tr>
<td>nucleoplasm</td><td>35</td><td>SNW1, PPIG, CHTOP, SF3B2, PNN, SETD2, BCLAF1, SART1, SF3B4, SRSF11, SRRM2, LUC7L3, SRSF4, PRPF40A, SRSF6, WTAP, SNRPA, BRD2, IK, RBM25, THRAP3, FNBP4, SF3B1, RBM17, PRPF4B, BCAS2, CCDC12, CWC25, CWF19L2, PLRG1, PPIE, PRPF19, SNRPA1, SNRPB2, SYF2</td></tr>
<tr>
<td>nucleus</td><td>33</td><td>SNW1, PPIG, CHTOP, SF3B2, SETD2, BCLAF1, SART1, SF3B4, ZC3H14, BMP2K, SRSF11, SRRM2, LUC7L3, GPATCH8, SRSF4, WTAP, CDK11A, SFSWAP, SNRPA, CDK11B, BRD2, IK, THRAP3, SF3B1, PRPF4B, BCAS2, CWC25, PLRG1, PPIE, PRPF19, SNRPA1, SNRPB2, SYF2</td></tr>
<tr>
<td>nuclear speck</td><td>32</td><td>SNW1, PPIG, CHTOP, SF3B2, PNN, BCLAF1, ZC3H18, SART1, ZC3H14, BMP2K, SRSF11, SRRM2, LUC7L3, SRSF4, PRPF40A, SRSF6, WTAP, BRD2, IK, RBM25, THRAP3, SF3B1, PRPF4B, SON, BCAS2, CWC25, PLRG1, PPIE, PRPF19, SNRPA1, SNRPB2, SYF2</td></tr>
<tr>
<td>RNA binding</td><td>31</td><td>SNW1, PPIG, CHTOP, SF3B2, PNN, UNK, BCLAF1, RSRC2, ZC3H18, SART1, SF3B4, ZC3H14, SRSF11, SRRM2, LUC7L3, GPATCH8, SRSF4, PRPF40A, SRSF6, SFSWAP, SNRPA, CDK11B, RBM25, THRAP3, SF3B1, RBM17, PRPF4B, SON, PPIE, SNRPA1, SYF2</td></tr>
<tr>
<td>mRNA splicing, via spliceosome</td><td>22</td><td>SNW1, SF3B2, PNN, SART1, SF3B4, SRRM2, SRSF4, PRPF40A, SRSF6, SNRPA, IK, SF3B1, PRPF4B, BCAS2, CWC25, CWF19L2, PLRG1, PPIE, PRPF19, SNRPA1, SNRPB2, SYF2</td></tr>
<tr>
<td>cytoplasm</td><td>15</td><td>PPIG, UNK, SETD2, BCLAF1, SART1, ZC3H14, BMP2K, WTAP, CDK11A, CDK11B, BRD2, IK, RBM25, PPIE, PRPF19</td></tr>
<tr>
<td>catalytic step 2 spliceosome</td><td>14</td><td>SNW1, SF3B2, PNN, SART1, SRRM2, SF3B1, PRPF4B, BCAS2, PLRG1, PPIE, PRPF19, SNRPA1, SNRPB2, SYF2</td></tr>
<tr>
<td>RNA splicing</td><td>14</td><td>PPIG, SF3B2, SF3B4, SRSF11, LUC7L3, SRSF4, WTAP, RBM25, THRAP3, SF3B1, PRPF4B, SON, BCAS2, SNRPA1</td></tr>
<tr>
<td>spliceosomal complex</td><td>11</td><td>SNW1, SF3B2, SF3B4, SNRPA, SF3B1, RBM17, BCAS2, PLRG1, PRPF19, SNRPA1, SNRPB2</td></tr>
<tr>
<td>U2-type catalytic step 2 spliceosome</td><td>9</td><td>SNW1, SRRM2, BCAS2, PLRG1, PPIE, PRPF19, SNRPA1, SNRPB2, SYF2</td></tr>
<tr>
<td>mRNA processing</td><td>8</td><td>SF3B2, SF3B4, SRSF11, SRSF4, WTAP, RBM25, THRAP3, SON</td></tr>
<tr>
<td>U2-type precatalytic spliceosome</td><td>8</td><td>SF3B2, SART1, SF3B4, SRRM2, IK, SF3B1, SNRPA1, SNRPB2</td></tr>
<tr>
<td>mRNA binding</td><td>6</td><td>CHTOP, SRRM2, LUC7L3, RBM25, SF3B1, PPIE</td></tr>
<tr>
<td>DNA binding</td><td>6</td><td>PNN, BCLAF1, LUC7L3, SNRPA, THRAP3, SON</td></tr>
<tr>
<td> transcription by RNA polymerase II</td><td>5</td><td>SNW1, BCLAF1, BRD2, THRAP3, SF3B1</td></tr>
<tr>
<td> mRNA splicing, via spliceosome</td><td>5</td><td>SNW1, SF3B4, THRAP3, SON, PRPF19</td></tr>
<tr>
<td>U2-type prespliceosome assembly</td><td>5</td><td>SF3B2, SF3B4, SF3B1, SNRPA1, SNRPB2</td></tr>
<tr>
<td>U2-type spliceosomal complex</td><td>5</td><td>SF3B2, SF3B4, SF3B1, CCDC12, CWC25</td></tr>
<tr>
<td>U2 snRNP</td><td>5</td><td>SF3B2, SF3B4, SF3B1, SNRPA1, SNRPB2</td></tr>
<tr>
<td>metal ion binding</td><td>5</td><td>UNK, SETD2, ZC3H18, ZC3H14, GPATCH8</td></tr>
<tr>
<td> DNA-templated transcription</td><td>5</td><td>SETD2, CDK11A, CDK11B, THRAP3, PPIE</td></tr>
<tr>
<td>ATP binding</td><td>5</td><td>BMP2K, CDK11A, CDK11B, THRAP3, PRPF4B</td></tr>
<tr>
<td>protein phosphorylation</td><td>5</td><td>BMP2K, CDK11A, CDK11B, BRD2, PRPF4B</td></tr>
<tr>
<td>nucleolus</td><td>4</td><td>CHTOP, ZC3H14, SF3B1, BCAS2</td></tr>
<tr>
<td>mRNA cis splicing, via spliceosome</td><td>4</td><td>SART1, PRPF40A, RBM17, PRPF4B</td></tr>
<tr>
<td>RNA splicing, via transesterification reactions</td><td>4</td><td>SF3B4, SRSF4, SF3B1, BCAS2</td></tr>
<tr>
<td>protein serine/threonine kinase activity</td><td>4</td><td>BMP2K, CDK11A, CDK11B, BRD2</td></tr>
<tr>
<td>protein serine kinase activity</td><td>4</td><td>BMP2K, CDK11A, CDK11B, PRPF4B</td></tr>
<tr>
<td>U1 snRNP</td><td>4</td><td>LUC7L3, PRPF40A, SNRPA, SNRPB2</td></tr>
<tr>
<td> alternative mRNA splicing, via spliceosome</td><td>4</td><td>SRSF6, WTAP, RBM25, THRAP3</td></tr>
<tr>
<td>identical protein binding</td><td>4</td><td>WTAP, SNRPA, IK, PRPF19</td></tr>
<tr>
<td>Prp19 complex</td><td>4</td><td>BCAS2, PLRG1, PRPF19, SYF2</td></tr>
<tr>
<td>nuclear matrix</td><td>3</td><td>SNW1, PPIG, PRPF40A</td></tr>
<tr>
<td>cytosol</td><td>3</td><td>PPIG, SART1, PPIE</td></tr>
<tr>
<td>in utero embryonic development</td><td>3</td><td>CHTOP, UNK, SYF2</td></tr>
<tr>
<td>U12-type spliceosomal complex</td><td>3</td><td>SF3B2, SF3B4, SF3B1</td></tr>
<tr>
<td>membrane</td><td>3</td><td>PNN, PRPF40A, PRPF19</td></tr>
<tr>
<td>apoptotic process</td><td>3</td><td>BCLAF1, CDK11A, CDK11B</td></tr>
<tr>
<td>U2-type prespliceosome</td><td>3</td><td>LUC7L3, PRPF40A, SF3B1</td></tr>
<tr>
<td>negative regulation of mRNA splicing, via spliceosome</td><td>3</td><td>SRSF4, SRSF6, SFSWAP</td></tr>
<tr>
<td>alternative mRNA splicing, via spliceosome</td><td>3</td><td>SRSF6, SFSWAP, RBM17</td></tr>
<tr>
<td>protein kinase activity</td><td>3</td><td>CDK11A, CDK11B, PRPF4B</td></tr>
<tr>
<td>cyclin-dependent protein serine/threonine kinase activity</td><td>3</td><td>CDK11A, CDK11B, PRPF4B</td></tr>
<tr>
<td>mitotic cell cycle</td><td>3</td><td>CDK11A, CDK11B, IK</td></tr>
<tr>
<td>post-mRNA release spliceosomal complex</td><td>3</td><td>CCDC12, CWF19L2, SYF2</td></tr>
<tr>
<td>transcription coactivator activity</td><td>2</td><td>SNW1, THRAP3</td></tr>
<tr>
<td>nuclear vitamin D receptor binding</td><td>2</td><td>SNW1, THRAP3</td></tr>
<tr>
<td>negative regulation of DNA-templated transcription</td><td>2</td><td>SNW1, BCLAF1</td></tr>
<tr>
<td>nuclear body</td><td>2</td><td>SNW1, SNRPA1</td></tr>
<tr>
<td>peptidyl-prolyl cis-trans isomerase activity</td><td>2</td><td>PPIG, PPIE</td></tr>
<tr>
<td>cyclosporin A binding</td><td>2</td><td>PPIG, PPIE</td></tr>
<tr>
<td>protein peptidyl-prolyl isomerization</td><td>2</td><td>PPIG, PPIE</td></tr>
<tr>
<td>protein folding</td><td>2</td><td>PPIG, PPIE</td></tr>
<tr>
<td>chromatin remodeling</td><td>2</td><td>CHTOP, SF3B1</td></tr>
<tr>
<td>neural tube closure</td><td>2</td><td>SETD2, BRD2</td></tr>
<tr>
<td> cytokinesis</td><td>2</td><td>SETD2, PRPF40A</td></tr>
<tr>
<td>chromosome</td><td>2</td><td>SETD2, PRPF4B</td></tr>
<tr>
<td>transcription coregulator activity</td><td>2</td><td>BCLAF1, THRAP3</td></tr>
<tr>
<td>DNA-templated transcription</td><td>2</td><td>BCLAF1, THRAP3</td></tr>
<tr>
<td> apoptotic process</td><td>2</td><td>BCLAF1, RBM25</td></tr>
<tr>
<td>mediator complex</td><td>2</td><td>BCLAF1, THRAP3</td></tr>
<tr>
<td>ribonucleoprotein complex</td><td>2</td><td>ZC3H18, ZC3H14</td></tr>
<tr>
<td>Cajal body</td><td>2</td><td>SART1, SRRM2</td></tr>
<tr>
<td>U4/U6 x U5 tri-snRNP complex</td><td>2</td><td>SART1, SNRPA</td></tr>
<tr>
<td>splicing factor binding</td><td>2</td><td>SF3B4, SF3B1</td></tr>
<tr>
<td>poly(A) binding</td><td>2</td><td>ZC3H14, PPIE</td></tr>
<tr>
<td>mRNA splice site recognition</td><td>2</td><td>LUC7L3, SRSF6</td></tr>
<tr>
<td>response to insulin</td><td>2</td><td>SRSF4, SRSF6</td></tr>
<tr>
<td>cell cycle</td><td>2</td><td>PRPF40A, WTAP</td></tr>
<tr>
<td>nuclear membrane</td><td>2</td><td>WTAP, PLRG1</td></tr>
<tr>
<td> cell growth</td><td>2</td><td>CDK11A, CDK11B</td></tr>
<tr>
<td> mitotic cell cycle</td><td>2</td><td>CDK11A, CDK11B</td></tr>
<tr>
<td> mRNA processing</td><td>2</td><td>CDK11A, CDK11B</td></tr>
<tr>
<td>U1 snRNA binding</td><td>2</td><td>SNRPA, SNRPB2</td></tr>
<tr>
<td>spermatogenesis</td><td>2</td><td>BRD2, SNRPA1</td></tr>
<tr>
<td>spliceosomal complex assembly</td><td>2</td><td>SF3B1, PRPF19</td></tr>
<tr>
<td> cell cycle</td><td>2</td><td>PRPF4B, SON</td></tr>
<tr>
<td>U2-type catalytic step 1 spliceosome</td><td>2</td><td>CWC25, PRPF19</td></tr>
<tr>
<td>fibrillar center</td><td>2</td><td>PLRG1, SNRPB2</td></tr>
</tbody>
</table>
</body>
</html>